ILMN
Illumina, Inc.
NasdaqGS · USD · Stock
$235.99
-36.01 (-13.24%)
past month
Closed- Market cap
- $35.68B
- P/E
- 40.62
- Volume
- 5.4M
- 52 weeks
- $113 – $309
About
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
Illumina, Inc. (ILMN) is a healthcare company listed on Nasdaq, traded in USD. Over the past year it moved between $112.65 and $309.35. The 20 analysts covering it say Hold, with an average price target of $261.60.
- Healthcare
- Diagnostics & Research
- San Diego, United States
- 8.6K employees
- Led by Jacob Thaysen Ph.D.
Financials
Revenue, last 12 months
$4.54B+4.20%
Earnings
Beat the estimate
4 of 4 quarters
Q4 2025
+9.69%
Q1 2026
+9.03%
Q2 2026
+6.82%
Q3 2026
+6.08%
Earnings per share, last 12 months $5.81
Analysts
20 analysts say
Hold
12-month target$261.60+10.85%
Dividends
Yield · per share, yearly
0.00%
Split 1,028-for-1,000 on Jun 25, 2024
Ownership
- Institutions
- 110.90%
- Insiders
- 0.21%
Latest insider trade Sep 8, 2026, COLETTI JULIE ANN
Prices from Yahoo Finance, may be delayed · Trending stocks today